Built by the people who have already changed this industry once.
Metamorphic AI was founded in 2026 in Denmark. We exist because the founders have seen, firsthand, what it looks like when this process works, and built the platform to make that possible at scale.
Our founding
Metamorphic AI was founded by Louise Lind Skov and Waheed Jowiya, bringing together over 20 years of combined experience across clinical development, digitalisation strategy, and pharmaceutical data science.
Before founding Metamorphic AI, the founding team led what became an industry-first digital transformation of the clinical documentation process at a major global pharmaceutical organisation. The results have not been replicated elsewhere at the same scale: timelines compressed from 12 weeks to minutes, resource requirements reduced by more than 90%, and a fundamental shift in what a small, highly capable team can produce.
That programme was not a pilot. It was run at production scale, across a live regulatory pipeline, under the scrutiny of internal QA and global regulatory agencies. What it demonstrated was not that automation could assist clinical documentation. It demonstrated that the process itself could be fundamentally redesigned.
Metamorphic AI was founded to make that transformation available to every organisation that needs it.
Our people
The founding team combines deep expertise across the disciplines that this problem actually requires: clinical medical writing, regulatory affairs, GxP-validated software development, and AI architecture.
We are not a technology company that discovered pharma. We are a team that has spent careers inside the regulatory documentation process, and built the platform from that vantage point.
Our engineering team brings long experience building software in highly regulated industries including pharmaceuticals, banking, and financial services. That background means the platform is built with the controls, validation disciplines, and auditability standards that regulated environments demand, not retrofitted to meet them after the fact.
Medical writing and regulatory affairs
Decades of experience producing regulatory submissions across global agencies, encoded into the platform's document generation logic.
Built for regulated environments
Engineers with careers spanning pharma, banking, and financial services, bringing the controls and validation disciplines that GxP environments require.
Purpose-built AI for compliance
Not general-purpose AI applied to pharma. Architecture designed from first principles around the traceability, consistency, and auditability the industry demands.
Our track record
Our approach
We are not a vendor. We deliver the outcome.
Every engagement begins with a structured conversation about your organisation's process, constraints, and timeline. We do not sell seats. We commit to outcomes: compression of time to document, reduction in resource dependency, and a validated audit trail that satisfies regulatory inspection from day one.